Hutch News

Molecular mechanisms of late cancer relapse

Molecular mechanisms of late cancer relapse

from the Chapuis lab, Clinical Research Division
Science Spotlight - October 15, 2018
Cancer cells evade immunotherapy by hiding telltale marker, suggesting how to stop relapse

Cancer cells evade immunotherapy by hiding telltale marker, suggesting how to stop relapse

A Nature Communications report explains why some Merkel cell carcinoma patients treated with immunotherapy see their cancers shrink at first but then come back.
News Releases - September 24, 2018
Triple therapy for rare skin cancer shows promise in small, early-stage trial

Triple therapy for rare skin cancer shows promise in small, early-stage trial

Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma
Hutch News - May 31, 2017
Immunotherapy shows promise in preventing leukemia relapse

Immunotherapy shows promise in preventing leukemia relapse

Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission
News Releases - December 05, 2016